References
- Spooner N , RamakrishnanY, BarfieldM, DewitO, MillerS. Use of DBS sample collection to determine circulating drug concentrations in clinical trials: practicalities and considerations. Bioanalysis2 (8), 1515–1522 (2010).
- Wilhelm AJ , Den BurgerJC, SwartEL. Therapeutic drug monitoring by dried blood spot: progress to date and future directions. Clin. Pharmacokinet. 53 (11), 961–973 (2014).
- Meesters RJ , HooffGP. State-of-the-art dried blood spot analysis: an overview of recent advances and future trends. Bioanalysis5 (17), 2187–2208 (2013).
- Cai X , ZhangJ, ShouWZ. Sample reduction strategies in discovery bioanalysis. Bioanalysis5 (13), 1691–1701 (2013).
- Zimmer JS , ChristiansonCD, JohnsonCJ, NeedhamSR. Recent advances in the bioanalytical applications of dried matrix spotting for the analysis of drugs and their metabolites. Bioanalysis5 (20), 2581–2588 (2013).
- Demirev PA . Dried blood spots: analysis and applications. Anal. Chem. 85 (2), 779–789 (2013).
- Enderle Y , FoersterK, BurhenneJ. Clinical feasibility of dried blood spots: analytics, validation and applications. J. Pharm. Biomed. Anal. 130, 231–243 (2016).
- Burnett JE . Dried blood spot sampling: practical considerations and recommendation for use with preclinical studies. Bioanalysis3 (10), 1099–1107 (2011).
- Kothare PA , BatemanKP, DockendorfMet al. An integrated strategy for implementation of dried blood spots in clinical development programs. AAPS J. 18 (2), 519–527 (2016).
- Chace DH , LimT, HansenCR, AdamBW, HannonWH. Quantification of malonylcarnitine in dried blood spots by use of MS/MS varies by stable isotope internal standard composition. Clin. Chim. Acta. 402 (1–2), 14–18 (2009).
- Gaissmaier T , SiebenhaarM, TodorovaV, HullenV, HopfC. Therapeutic drug monitoring in dried blood spots using liquid microjunction surface sampling and high-resolution mass spectrometry. Analyst141 (3), 892–901 (2016).
- Ignjatovic V , PittJ, MonagleP, CraigJM. The utility of dried blood spots for proteomic studies: looking forward to looking back. Proteomics Clin. Appl. 8 (11–12), 896–900 (2014).
- D’arienzo CJ , JiQC, DiscenzaLet al. DBS sampling can be used to stabilize prodrugs in drug discovery rodent studies without the addition of esterase inhibitors. Bioanalysis2 (8), 1415–1422 (2010).
- Rao RN , MauryaPK, RameshM, SrinivasR, AgwaneSB. Development of a validated high-throughput LC–ESI–MS method for determination of sirolimus on dried blood spots. Biomed. Chromatogr. 24 (12), 1356–1364 (2010).
- Meesters RJ , HooffGP, GrutersR, Van KampenJJ, LuiderTM. Incurred sample reanalysis comparison of dried blood spots and plasma samples on the measurement of lopinavir in clinical samples. Bioanalysis4 (3), 237–240 (2012).
- Li W , ZhangJ, TseFL. Strategies in quantitative LC–MS/MS analysis of unstable small molecules in biological matrices. Biomed. Chromatogr. 25 (1–2), 258–277 (2011).
- De Kesel PM , SadonesN, CapiauS, LambertWE, StoveCP. Hemato-critical issues in quantitative analysis of dried blood spots: challenges and solutions. Bioanalysis5 (16), 2023–2041 (2013).
- Robijns K , KosterRA, TouwDJ. Therapeutic drug monitoring by dried blood spot: progress to date and future directions. Clin. Pharmacokinet. 53 (11), 1053 (2014).
- Jager NG , RosingH, SchellensJH, BeijnenJH. Procedures and practices for the validation of bioanalytical methods using dried blood spots: a review. Bioanalysis6 (18), 2481–2514 (2014).
- Zheng N , YuanL, JiQCet al. ‘Center punch’ and ‘whole spot’ bioanalysis of apixaban in human dried blood spot samples by UHPLC–MS/MS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 988, 66–74 (2015).
- Zimmer D , HasslerS, BetschartB, SackS, FankhauserC, LoppacherM. Internal standard application to dried blood spots by spraying: investigation of the internal standard distribution. Bioanalysis5 (6), 711–719 (2013).
- Abu-Rabie P , DenniffP, SpoonerN, BrynjolffssenJ, GalluzzoP, SandersG. Method of applying internal standard to dried matrix spot samples for use in quantitative bioanalysis. Anal. Chem. 83 (22), 8779–8786 (2011).